银杏达莫注射液对糖尿病视网膜病变血浆内皮素的影响
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:


Effects of the ginkgo biloba injection on plasma endothelin in diabetic retinopathy
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:探讨中药杏丁叶提取物银杏达莫注射液拮抗糖尿病患者内皮素的作用。方法:观察各期Ⅱ型糖尿病患者58例,用银杏达莫注射液25mL加入生理盐水250mL中,1次/d,15d为一疗程,测定治疗前后血浆内皮素含量。结果:治疗前平均血浆内皮素78.32pg/mL,(参考值:37.91~68.37pg/mL),最高105.68pg/mL,治疗后平均血浆内皮素水平59.57pg/mL,平均下降18.75pg/mL,差异具有统计学意义(P<0.05)。结论:银杏达莫注射液能有效降低糖尿病患者血浆内皮素水平,对糖尿病性视网膜病变患者有治疗作用。

    Abstract:

    AIM: To discuss the antagonistic role of traditional Chinese medicine leaf of xingding extract-the ginkgo biloba injection on endothelin(ET) in diabetic retinopathy(DR) patients. METHODS: A total of 58 DR patients were enrolled in the study, DR patients were administered with 25mL ginkgo-dipyridamolum injection which was dissolved in 250mL normal saline, once a day for 15 days. The ET in their peripheral blood was measured before and after treatment. RESULTS: The mean value of plasma ET before treatment was 78.32pg/mL (reference value: 37.91-68.37pg/mL) and the highest value was 105.68pg/mL. The mean plasma ET level after treatment was 59.57pg/mL, which averagely decreased 18.75pg/mL as compared with that before the treatment. There was a significant difference between them(P<0.05). CONCLUSION: The ginkgo biloba injection can effectively decrease the plasma ET level of DR patients, which has a therapeutic effect on DR.

    参考文献
    相似文献
    引证文献
引用本文

晏世刚,黄慧君,肖泽锋,等.银杏达莫注射液对糖尿病视网膜病变血浆内皮素的影响.国际眼科杂志, 2010,10(4):764-765.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期:
  • 出版日期:
文章二维码